{"hands_on_practices": [{"introduction": "Effective management of vesicoureteral reflux (VUR) begins with accurate diagnosis and staging. This practice problem bridges the gap between interpreting diagnostic imaging and formulating an initial clinical plan. By analyzing a classic patient vignette and the findings from a Voiding Cystourethrogram (VCUG), you will apply the International Reflux Study grading system, a critical skill that directly informs prognosis and guides the choice between observation, medical prophylaxis, or surgical intervention. [@problem_id:5217201]", "problem": "A child presents for evaluation of Vesicoureteral Reflux (VUR). Consider the following scenario and choose the single best option that correctly assigns the reflux grade and selects the most appropriate initial management.\n\nA female child aged $18$ months has had $2$ culture-proven febrile Urinary Tract Infections (UTIs) in the past $6$ months. Renal ultrasound shows kidneys of normal size with no hydronephrosis. Dimercaptosuccinic acid (DMSA) renal scan shows no cortical defects. Serum creatinine is $0.3$ mg/dL. Voiding cystourethrogram (VCUG) demonstrates retrograde filling of the ureter and renal pelvis during bladder filling and voiding, with a mildly dilated ureter, blunted calyces, and no significant ureteral tortuosity. The bladder appears normal, with no posterior urethral valves and minimal post-void residual.\n\nStarting from foundational principles, recall that VUR is retrograde urine flow from bladder to ureter/renal pelvis due to an incompetent vesicoureteral junction, driven by a pressure gradient during bladder filling and voiding. The International Reflux Study grading system classifies VUR by the extent of retrograde flow and the morphological consequences in the upper tract: none/minimal dilation with sharp calyces versus progressive dilation, calyceal blunting, and ureteral tortuosity at higher grades. Correlate the imaging descriptors in this case with the grading definitions and then select the management option that best aligns with the natural history and risk of renal injury at the corresponding grade, given the clinical context of recurrent febrile UTIs and no existing scarring.\n\nWhich option is most appropriate?\n\nA. Grade $II$ VUR; observation without Continuous Antibiotic Prophylaxis (CAP) and repeat VCUG in $12$ months.\n\nB. Grade $III$ VUR; initiate Continuous Antibiotic Prophylaxis (CAP) with urine-culture surveillance and follow-up imaging (VCUG or renal scan) in $12$–$24$ months.\n\nC. Grade $IV$ VUR; proceed to ureteral reimplantation now due to high risk of obstruction.\n\nD. Grade $III$ VUR; immediate endoscopic injection (e.g., bulking agent) in all cases regardless of infection history or scarring.", "solution": "The problem requires a two-step analysis: first, grading the Vesicoureteral Reflux (VUR) based on the Voiding Cystourethrogram (VCUG) description, and second, selecting the most appropriate initial management based on the grade and the clinical context.\n\n**Step 1: Grade the Vesicoureteral Reflux**\n\nThe VCUG findings are described as \"retrograde filling of the ureter and renal pelvis... with a mildly dilated ureter, blunted calyces, and no significant ureteral tortuosity.\" We correlate this with the International Reflux Study grading system:\n*   **Grade I:** Reflux into the ureter only. (Incorrect, as it reaches the renal pelvis).\n*   **Grade II:** Reflux into the ureter and renal pelvis/calyces without dilation. (Incorrect, as mild dilation and blunting are present).\n*   **Grade III:** Mild to moderate dilation of the ureter and/or renal pelvis, with minimal blunting of the calyceal fornices. (This description accurately matches the findings).\n*   **Grade IV:** Moderate dilation and tortuosity of the ureter, with clear blunting of the fornices. (Incorrect, as the description notes \"no significant ureteral tortuosity\").\n*   **Grade V:** Gross dilation and marked tortuosity. (Incorrect).\nTherefore, the correct reflux grade is **Grade III**.\n\n**Step 2: Determine Appropriate Initial Management**\n\nThe patient is an 18-month-old female with a history of two febrile Urinary Tract Infections (UTIs) and newly diagnosed Grade III VUR. The DMSA scan is normal, indicating no pre-existing renal scarring. The primary goal of management is to prevent future febrile UTIs and subsequent renal scarring.\n\nLet's evaluate the options:\n*   **A. Grade II VUR; observation without Continuous Antibiotic Prophylaxis (CAP)...**: The grade is incorrect. Furthermore, observation without prophylaxis is inappropriate for a young child who has already experienced two febrile UTIs, as this indicates a high risk for recurrence and renal injury.\n*   **B. Grade III VUR; initiate Continuous Antibiotic Prophylaxis (CAP) with urine-culture surveillance and follow-up imaging...**: The grade is correct. For a young child with Grade III VUR and a history of recurrent febrile UTIs, initiating CAP is the standard of care. This approach aims to keep the urine sterile, preventing pyelonephritis while allowing time for potential spontaneous resolution of the reflux. Regular follow-up is also a key component. This is the most appropriate initial management strategy.\n*   **C. Grade IV VUR; proceed to ureteral reimplantation now...**: The grade is incorrect. Moreover, immediate surgical intervention is generally not the first-line treatment for Grade III VUR in a young child without evidence of new scarring or breakthrough infections while on CAP.\n*   **D. Grade III VUR; immediate endoscopic injection...**: While the grade is correct, immediate surgical correction is not typically the initial step for all children with Grade III VUR. Medical management with CAP is a well-established and less invasive first-line approach. The absolute statement \"in all cases regardless of infection history or scarring\" is incorrect and contradicts the principles of individualized care.\n\n**Conclusion:**\nBased on the accurate grading of VUR as Grade III and the clinical history of recurrent febrile UTIs, the most appropriate initial management is to initiate Continuous Antibiotic Prophylaxis (CAP) to prevent further infections and protect the kidneys from scarring.", "answer": "$$\\boxed{B}$$", "id": "5217201"}, {"introduction": "Once a decision is made for medical management, precision in pharmacotherapy is paramount to success. This exercise focuses on the practical application of prescribing continuous antibiotic prophylaxis (CAP), a cornerstone of conservative VUR management. You will perform weight-based dose calculations for common prophylactic agents and, critically, learn to adjust these doses based on the patient's renal function, a fundamental skill to ensure efficacy while safeguarding against drug toxicity. [@problem_id:5217185]", "problem": "A child with Vesicoureteral Reflux (VUR) weighing $15\\,\\mathrm{kg}$ is placed on once-daily urinary tract infection prophylaxis. Two commonly used agents are Trimethoprim-Sulfamethoxazole (TMP-SMX) and nitrofurantoin. For TMP-SMX, the prophylactic dose is specified as $2\\,\\mathrm{mg/kg}$ of the trimethoprim component once daily. For nitrofurantoin, the prophylactic dose is $1.5\\,\\mathrm{mg/kg}$ once daily. The child’s estimated Glomerular Filtration Rate (eGFR) is $40\\,\\mathrm{mL/min/1.73\\,m^{2}}$. Use the following well-tested pharmacotherapeutic facts as the fundamental base for your reasoning:\n- In pediatric weight-based dosing, the administered mass scales linearly with body mass.\n- Renal dosing adjustments are indicated when renal clearance is reduced. For TMP-SMX, no dose reduction is recommended when the eGFR is at least $30\\,\\mathrm{mL/min/1.73\\,m^{2}}$. For nitrofurantoin, use is generally avoided if eGFR is less than $30\\,\\mathrm{mL/min/1.73\\,m^{2}}$; no dose reduction is recommended when eGFR is at least $30\\,\\mathrm{mL/min/1.73\\,m^{2}}$.\n\nAssuming both agents were (counterfactually) prescribed concurrently, calculate the combined adjusted daily mass that would be administered under these renal function conditions. Round your answer to four significant figures. Express the final mass in milligrams (mg).", "solution": "The problem is validated as scientifically grounded, well-posed, and free of contradictions. The provided data are sufficient and consistent for a unique solution. The question is a straightforward application of pharmacotherapeutic principles involving weight-based dosing and renal function adjustments.\n\nThe task is to calculate the combined daily mass of two prophylactic agents, Trimethoprim-Sulfamethoxazole (TMP-SMX) and nitrofurantoin, for a child with specified weight and renal function. The problem explicitly states that the concurrent prescription is a counterfactual assumption for the purpose of this calculation.\n\nFirst, we identify the given parameters:\nChild's body mass, $m_{child} = 15\\,\\mathrm{kg}$.\nProphylactic dose rate of the trimethoprim component of TMP-SMX, $D_{TMP-SMX} = 2\\,\\mathrm{mg/kg}$ per day.\nProphylactic dose rate of nitrofurantoin, $D_{Nito} = 1.5\\,\\mathrm{mg/kg}$ per day.\nChild's estimated Glomerular Filtration Rate, $eGFR = 40\\,\\mathrm{mL/min/1.73\\,m^{2}}$.\n\nNext, we must assess the need for dose adjustments based on the child's renal function. The problem provides the following criteria:\nFor TMP-SMX, no dose reduction is recommended when $eGFR$ is at least $30\\,\\mathrm{mL/min/1.73\\,m^{2}}$.\nFor nitrofurantoin, no dose reduction is recommended when $eGFR$ is at least $30\\,\\mathrm{mL/min/1.73\\,m^{2}}$.\n\nThe child's $eGFR$ is given as $40\\,\\mathrm{mL/min/1.73\\,m^{2}}$. We compare this value to the specified thresholds.\nFor TMP-SMX: Since $40\\,\\mathrm{mL/min/1.73\\,m^{2}} \\ge 30\\,\\mathrm{mL/min/1.73\\,m^{2}}$, no dose adjustment is required.\nFor nitrofurantoin: Since $40\\,\\mathrm{mL/min/1.73\\,m^{2}} \\ge 30\\,\\mathrm{mL/min/1.73\\,m^{2}}$, no dose adjustment is required. The contraindication for $eGFR < 30\\,\\mathrm{mL/min/1.73\\,m^{2}}$ is not applicable here.\n\nTherefore, we can calculate the daily mass for each drug using the standard weight-based dosing formulas.\n\nLet $M_{TMP-SMX}$ be the daily mass of the trimethoprim component. This is calculated by multiplying the dose rate by the child's mass:\n$$M_{TMP-SMX} = D_{TMP-SMX} \\times m_{child}$$\n$$M_{TMP-SMX} = (2\\,\\mathrm{mg/kg}) \\times (15\\,\\mathrm{kg}) = 30\\,\\mathrm{mg}$$\n\nLet $M_{Nito}$ be the daily mass of nitrofurantoin. This is calculated similarly:\n$$M_{Nito} = D_{Nito} \\times m_{child}$$\n$$M_{Nito} = (1.5\\,\\mathrm{mg/kg}) \\times (15\\,\\mathrm{kg}) = 22.5\\,\\mathrm{mg}$$\n\nThe problem asks for the combined adjusted daily mass, which we denote as $M_{total}$. This is the sum of the individual masses:\n$$M_{total} = M_{TMP-SMX} + M_{Nito}$$\n$$M_{total} = 30\\,\\mathrm{mg} + 22.5\\,\\mathrm{mg} = 52.5\\,\\mathrm{mg}$$\n\nThe problem requires the answer to be rounded to four significant figures. The calculated value $52.5$ has three significant figures. To express this with four significant figures, we add a trailing zero.\n$$M_{total} = 52.50\\,\\mathrm{mg}$$", "answer": "$$\\boxed{52.50}$$", "id": "5217185"}, {"introduction": "The clinical picture in VUR is often more complex than the reflux itself, especially in cases of recurrent infection despite apparently successful treatment. This advanced scenario challenges you to engage in higher-order clinical reasoning, looking beyond the primary diagnosis of VUR. It emphasizes the critical importance of identifying and managing comorbidities, such as bladder-bowel dysfunction (BBD), and considering potential iatrogenic complications, which are often the true drivers of persistent morbidity. [@problem_id:5217206]", "problem": "A child presents to the pediatric urology clinic with recurrent febrile urinary tract infections despite documented resolution of vesicoureteral reflux. A $5$-year-old girl had primary bilateral vesicoureteral reflux (defined as retrograde urine flow from bladder into ureter and kidney during filling or voiding) graded II–III on voiding cystourethrogram (VCUG) at age $4$ years. Eight months ago, she underwent endoscopic injection with dextranomer/hyaluronic acid copolymer (Dx/HA), and a post-procedural VCUG at $3$ months demonstrated no reflux. Over the past $6$ months, she has had $3$ culture-proven febrile urinary tract infections with Escherichia coli sensitive to third-generation cephalosporins but resistant to trimethoprim-sulfamethoxazole. She is not sexually active. Parents report daytime urgency, infrequent voiding (approximately $3$ times per day), holding maneuvers, and hard stools consistent with constipation. Physical examination reveals palpable stool in the left lower quadrant and mild suprapubic tenderness; neurologic examination, including lower extremity tone, perineal sensation, and reflexes, is normal, with no cutaneous stigmata over the lumbosacral spine. Renal-bladder ultrasonography (RBUS) shows normal renal size and parenchyma with new mild right-sided hydronephrosis (Society for Fetal Urology grade I), bladder wall thickening, and a post-void residual of approximately $70$ mL measured by ultrasound. Serum creatinine and blood pressure are normal. \n\nGrounded in the following foundational facts:\n- Bacterial urinary tract infections commonly arise via ascending periurethral colonization; efficient bladder emptying and low intravesical pressures reduce risk by limiting residual urine and reflux of infected urine.\n- Vesicoureteral reflux (VUR) increases risk of pyelonephritis by facilitating ascent of infected urine to the upper tract; however, recurrent febrile infections after documented resolution of VUR prompt evaluation for alternative mechanisms such as bladder-bowel dysfunction, anatomical or iatrogenic obstruction, and host defense abnormalities.\n- Expected functional bladder capacity in children can be approximated by widely accepted pediatric urology nomograms; one commonly used estimate is capacity (mL) $\\approx \\text{age (years)} \\times 30 + 30$.\n- Diuretic renography with Technetium-$^{99\\mathrm{m}}$ mercaptoacetyltriglycine (MAG3) can objectively assess differential renal function and drainage to detect obstruction.\n- Uroflowmetry with pelvic floor electromyography (EMG), post-void residual measurement, voiding diaries, and constipation assessment are standard tools to diagnose bladder-bowel dysfunction.\n\nWhich of the following are the most appropriate next evaluations to investigate etiologies beyond reflux that plausibly account for this child’s recurrent febrile urinary tract infections? Select ALL that apply.\n\nA. Comprehensive bladder-bowel dysfunction assessment including uroflowmetry with pelvic floor electromyography, repeat post-void residual measurements across multiple voids, a structured voiding diary, and targeted constipation evaluation with initiation of a bowel regimen.\n\nB. Immediate reinstatement of continuous broad-spectrum antibiotic prophylaxis indefinitely without further diagnostic work-up, given recurrent febrile infections.\n\nC. Immediate repeat voiding cystourethrogram to search for recurrent low-grade reflux despite prior documented resolution, as the first-line test.\n\nD. Diuretic renography (Technetium-$^{99\\mathrm{m}}$ MAG3) to evaluate for ureterovesical junction obstruction potentially induced by dextranomer/hyaluronic acid injection, given the new mild hydronephrosis and recurrent febrile infections.\n\nE. Immunologic work-up including quantitative immunoglobulins (IgG, IgA, IgM), total hemolytic complement, and neutrophil oxidative burst testing for chronic granulomatous disease, based on the recurrence despite appropriate therapy.\n\nF. Spinal magnetic resonance imaging of the lumbosacral spine to evaluate for an occult tethered cord despite normal neurologic examination and lack of cutaneous stigmata.", "solution": "The problem statement is subjected to validation before proceeding to a solution.\n\n### Step 1: Extract Givens\n- **Patient Profile:** A $5$-year-old girl.\n- **Presenting Complaint:** Recurrent febrile urinary tract infections (UTIs).\n- **Past Medical History:** Primary bilateral vesicoureteral reflux (VUR), grade II–III, diagnosed at age $4$ years.\n- **Past Surgical History:** Endoscopic injection with dextranomer/hyaluronic acid copolymer (Dx/HA) $8$ months ago.\n- **Follow-up Data:** A post-procedural voiding cystourethrogram (VCUG) at $3$ months post-procedure demonstrated no reflux.\n- **Interval History:** Over the past $6$ months, she has had $3$ culture-proven febrile UTIs with Escherichia coli sensitive to third-generation cephalosporins but resistant to trimethoprim-sulfamethoxazole.\n- **Social History:** Not sexually active.\n- **Reported Symptoms:** Daytime urgency, infrequent voiding (approximately $3$ times per day), holding maneuvers, and hard stools consistent with constipation.\n- **Physical Examination:** Palpable stool in the left lower quadrant; mild suprapubic tenderness; normal neurologic examination (lower extremity tone, perineal sensation, and reflexes); no cutaneous stigmata over the lumbosacral spine.\n- **Imaging:** Renal-bladder ultrasonography (RBUS) shows normal renal size and parenchyma with new mild right-sided hydronephrosis (Society for Fetal Urology grade I), bladder wall thickening, and a post-void residual (PVR) of approximately $70$ mL.\n- **Laboratory Data:** Serum creatinine and blood pressure are normal.\n- **Foundational Fact 1:** Efficient bladder emptying and low intravesical pressures reduce UTI risk.\n- **Foundational Fact 2:** Recurrent febrile UTIs after VUR resolution prompt evaluation for alternative mechanisms such as bladder-bowel dysfunction (BBD), obstruction, and host defense abnormalities.\n- **Foundational Fact 3:** Expected bladder capacity in children (mL) $\\approx \\text{age (years)} \\times 30 + 30$.\n- **Foundational Fact 4:** Diuretic renography with Technetium-$^{99\\mathrm{m}}$ mercaptoacetyltriglycine (MAG3) assesses differential renal function and drainage to detect obstruction.\n- **Foundational Fact 5:** Uroflowmetry with pelvic floor electromyography (EMG), PVR measurement, voiding diaries, and constipation assessment are standard tools to diagnose BBD.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is well-defined and internally consistent.\n- **Scientifically Grounded:** The clinical scenario is a classic presentation in pediatric urology. The pathophysiology described, diagnostic modalities mentioned, and the principles provided are all rooted in established medical science.\n- **Well-Posed:** The problem provides sufficient, relevant data to allow for a reasoned decision on the most appropriate next steps in diagnosis. The question is specific and answerable.\n- **Objective:** The presentation is objective, using precise clinical terminology and reporting quantitative findings (e.g., PVR of $70$ mL, $3$ UTIs in $6$ months).\n- **Completeness and Consistency:** The data are complete and consistent. The history of VUR and its treatment, followed by recurrent UTIs, coupled with new symptoms and ultrasound findings, creates a coherent clinical puzzle. There are no contradictions. The provided foundational facts serve as axioms for solving the problem.\n\n### Step 3: Verdict and Action\nThe problem statement is valid. The solution process will now proceed.\n\n### Derivation of the Solution\nThe central clinical issue is the recurrence of febrile UTIs in a child whose VUR has been successfully treated, as documented by a post-procedural VCUG. According to the foundational facts, this situation mandates a search for alternative or co-existing etiologies. The clinical data point strongly toward two specific pathologies.\n\n**1. Bladder-Bowel Dysfunction (BBD):**\nThe evidence for BBD is compelling. The patient exhibits a classic symptom cluster:\n- **Bowel Dysfunction:** Constipation with hard stools and palpable stool on examination. A full rectum can mechanically compress the bladder, leading to incomplete emptying and sensory alteration.\n- **Bladder Dysfunction:** Symptoms include infrequent voiding (~$3$ times per day, which is low for a child), urgency, and holding maneuvers. These behaviors lead to bladder overdistension and high storage pressures.\n- **Objective Findings:** The RBUS reveals bladder wall thickening, which is indicative of chronic high-pressure storage or voiding against a poorly relaxed sphincter. Critically, the post-void residual (PVR) volume is $70$ mL. Using the provided formula, the expected bladder capacity (EBC) for a $5$-year-old is:\n$$ \\text{EBC} \\approx (5 \\times 30 + 30) \\text{ mL} = 180 \\text{ mL} $$\nA PVR of $70$ mL represents approximately $39\\%$ of her expected capacity ($70/180 \\approx 0.389$). A PVR greater than $20$ mL or $>10\\%$ of bladder capacity is generally considered abnormal. This degree of incomplete bladder emptying provides a static reservoir of urine, an ideal medium for bacterial proliferation, directly increasing the risk of UTI as per Foundational Fact 1.\n\n**2. Ureteral Obstruction:**\nThe RBUS shows \"new mild right-sided hydronephrosis.\" This is a significant finding that cannot be ignored, especially in the context of febrile UTIs. The patient underwent Dx/HA injection into the ureterovesical junction (UVJ) to correct VUR. A known, though uncommon, complication of this procedure is iatrogenic UVJ obstruction, where the injected bulk narrows the ureteral orifice, impeding urine flow from the kidney to the bladder. This leads to urine stasis in the upper tract (hydronephrosis) and predisposes the kidney to infection (pyelonephritis, i.e., febrile UTI). The concurrence of febrile UTIs and new hydronephrosis post-injection makes the evaluation for obstruction a high priority.\n\nBased on this analysis, the most appropriate next steps must address these two highly plausible etiologies.\n\n### Evaluation of Options\n\n**A. Comprehensive bladder-bowel dysfunction assessment including uroflowmetry with pelvic floor electromyography, repeat post-void residual measurements across multiple voids, a structured voiding diary, and targeted constipation evaluation with initiation of a bowel regimen.**\nThis option directly investigates the most evident pathology presented in the case: BBD. The listed components (uroflow/EMG, diaries, PVRs, constipation management) are the standard diagnostic and initial management tools, as per Foundational Fact 5. A formal assessment is necessary to characterize the specific type of dysfunction (e.g., overactive bladder, dysfunctional voiding, underactive bladder) and to guide targeted behavioral and medical therapy. Given the profound impact of BBD on UTI risk, this is an essential and highly appropriate next step.\n**Verdict: Correct.**\n\n**B. Immediate reinstatement of continuous broad-spectrum antibiotic prophylaxis indefinitely without further diagnostic work-up, given recurrent febrile infections.**\nThis approach is purely palliative and fails to address the underlying pathophysiology. While temporary prophylaxis might be considered as a bridging measure, instituting it \"indefinitely without further diagnostic work-up\" constitutes substandard medical practice. It allows the root causes (BBD and/or obstruction) to persist, potentially leading to progressive renal damage, and contributes to the development of antibiotic resistance. The pathogen is already resistant to one common prophylactic agent.\n**Verdict: Incorrect.**\n\n**C. Immediate repeat voiding cystourethrogram to search for recurrent low-grade reflux despite prior documented resolution, as the first-line test.**\nWhile VUR can recur after endoscopic treatment, a VCUG performed only $5$ months prior was negative. The clinical evidence for BBD and the new finding of hydronephrosis are far more compelling and point to different diagnoses. A VCUG is invasive and involves radiation exposure. It is not the most logical or highest-yield *first-line* test in this specific clinical context. Investigating BBD and the cause of the hydronephrosis takes clear precedence.\n**Verdict: Incorrect.**\n\n**D. Diuretic renography (Technetium-$^{99\\mathrm{m}}$ MAG3) to evaluate for ureterovesical junction obstruction potentially induced by dextranomer/hyaluronic acid injection, given the new mild hydronephrosis and recurrent febrile infections.**\nThis option directly addresses the \"new mild right-sided hydronephrosis,\" a serious finding suggesting impaired urine drainage from the kidney. As per Foundational Fact 4, diuretic renography is the definitive non-invasive test to quantify renal function and drainage, thereby confirming or refuting the presence of a clinically significant obstruction. Given the history of Dx/HA injection, iatrogenic obstruction is a distinct possibility that must be evaluated urgently, as obstruction with infection can rapidly damage the kidney.\n**Verdict: Correct.**\n\n**E. Immunologic work-up including quantitative immunoglobulins (IgG, IgA, IgM), total hemolytic complement, and neutrophil oxidative burst testing for chronic granulomatous disease, based on the recurrence despite appropriate therapy.**\nWhile recurrent infections can be a sign of primary immunodeficiency, such a work-up is not indicated as a primary step here. The patient has a very clear set of localizing urological and gastrointestinal findings (BBD, potential obstruction) that are well-established, potent risk factors for UTIs. A systemic immune defect is much lower on the differential diagnosis. This work-up would only be considered if UTIs persist despite correction of all identified anatomic and functional abnormalities.\n**Verdict: Incorrect.**\n\n**F. Spinal magnetic resonance imaging of the lumbosacral spine to evaluate for an occult tethered cord despite normal neurologic examination and lack of cutaneous stigmata.**\nA neurogenic cause of bladder dysfunction (e.g., tethered cord syndrome) is a possibility in any child with voiding dysfunction. However, in this case, the neurologic examination is explicitly normal, and there are no cutaneous markers of spinal dysraphism. These findings make an occult neurogenic etiology far less likely than functional BBD, for which there is abundant positive evidence. An MRI is an expensive, resource-intensive test that requires sedation in a young child and is not warranted as a primary investigation in this setting.\n**Verdict: Incorrect.**", "answer": "$$\\boxed{AD}$$", "id": "5217206"}]}